We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




World’s First Rapid Saliva-Based Pregnancy Test Eliminates Need for Blood and Urine Samples

By LabMedica International staff writers
Posted on 09 Dec 2022
Print article
Image: Salistick is the first rapid saliva-based pregnancy test (Photo courtesy of Salignostics)
Image: Salistick is the first rapid saliva-based pregnancy test (Photo courtesy of Salignostics)

Saliva contains over 5,000 identified proteins. With significant overlap to blood, saliva is considered the second most important body-fluid for diagnostics. Saliva is a complex fluid which contains markers for several diseases and a variety of hormones. The level of those hormones is significantly lower than in serum/blood or urine. Therefore, only a sensitive test will allow their detection. During pregnancy, the body produces the pregnancy hormone, hCG (human chorionic gonadotropin). A portion of this hormone travels from the blood to the saliva. Levels of hCG continue to increase rapidly during the first three months of pregnancy. Now, a unique pregnancy test that can detect even the low levels of hCG in saliva, could spell the end of traditional tests involving urinating on a stick.

Salistick from Salignostics (Jerusalem, Israel) is the first rapid saliva-based pregnancy test for early and highly accurate pregnancy detection that does not require urine. The kit is based on the company’s revolutionary technology which detects the pregnancy hormone β-hCG in saliva from the first day of the missed period. The amount of this hormone increases as pregnancy progresses. The pregnancy test kit contains a sealed pouch with a collection handle, analytical unit and a preservative silica bag (to be tossed away), along with instructions for use.

The collection foam absorbs saliva from the mouth. When the user connects the collection handle to the analytical unit, the saliva is squeezed and migrates along a special membrane until it reaches the test zone. In the presence of the hCG pregnancy hormone, a pink line appears. The absence of this test line suggests a negative result. A pink control line appears if the test was performed properly. The test can be easily performed at home at any time of the day (30 minutes after drinking or eating). In laboratory testing with saliva samples of pregnant women from the first day after their missed period, SaliStick test gave 95% positive results. SaliStick is expected to be available for purchase in several European countries, as well as South Africa, UAE, and Israel from the first quarter of 2023. Salignostics is also developing other tests, including kits for detection of malaria, cardiac risk and H. pylori bacteria.

Related Links:
Salignostics

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The AI model accurately classifies pediatric sarcomas using digital pathology images alone (Photo courtesy of 123RF)

AI-Driven Analysis of Digital Pathology Images to Improve Pediatric Sarcoma Subtyping

Pediatric sarcomas are rare and diverse tumors that can develop in various types of soft tissue, such as muscle, tendons, fat, blood or lymphatic vessels, nerves, or the tissue surrounding joints.... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.